Financials Bigtincan Holdings Limited

Equities

BTH

AU000000BTH6

Biotechnology & Medical Research

Market Closed - Australian S.E. 02:10:37 2024-05-17 am EDT 5-day change 1st Jan Change
0.145 AUD -6.45% Intraday chart for Bigtincan Holdings Limited -3.33% -27.50%

Valuation

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 135.2 276.8 471.3 276.2 309.7 95.52 - -
Enterprise Value (EV) 1 110 205.4 415 237.2 276.1 78.93 81.44 71.69
P/E ratio -28.7 x -18.2 x -26.3 x -10.1 x - - 17.2 x 14.1 x
Yield - - - - - - - -
Capitalization / Revenue 6.8 x 8.93 x 10.7 x 2.56 x 2.53 x 0.77 x 0.78 x 0.75 x
EV / Revenue 5.53 x 6.63 x 9.46 x 2.2 x 2.26 x 0.64 x 0.67 x 0.56 x
EV / EBITDA -28.7 x -30.5 x -68.1 x 57.8 x 33.2 x 5.06 x 4.88 x 4.1 x
EV / FCF -16.3 x -15.1 x -24.2 x -1.62 x -22.9 x -7.45 x 18.1 x 11.4 x
FCF Yield -6.13% -6.61% -4.13% -61.8% -4.36% -13.4% 5.53% 8.79%
Price to Book 4.16 x 3.4 x 4.58 x 1.26 x 1.36 x 0.44 x 0.46 x 0.43 x
Nbr of stocks (in thousands) 259,937 376,562 415,221 552,350 607,253 616,253 - -
Reference price 2 0.5200 0.7350 1.135 0.5000 0.5100 0.1550 0.1550 0.1550
Announcement Date 8/28/19 8/25/20 8/25/21 8/29/22 8/30/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 19.88 31.01 43.87 108 122.4 123.5 122.3 127.4
EBITDA 1 -3.84 -6.735 -6.09 4.106 8.323 15.6 16.7 17.5
EBIT 1 -4.3 -8.771 -8.707 -7.316 -11.59 0.7468 2.679 5.268
Operating Margin -21.63% -28.29% -19.85% -6.77% -9.47% 0.6% 2.19% 4.13%
Earnings before Tax (EBT) -4.046 -12.13 -15.03 -22.36 - - 5.7 6.5
Net income 1 -4.132 -12.21 -13.89 -21.15 -23.87 -9.9 5.7 6.5
Net margin -20.78% -39.37% -31.66% -19.58% -19.5% -8.01% 4.66% 5.1%
EPS -0.0181 -0.0403 -0.0431 -0.0494 - - 0.009000 0.0110
Free Cash Flow 1 -6.749 -13.58 -17.15 -146.6 -12.05 -10.6 4.5 6.3
FCF margin -33.95% -43.81% -39.1% -135.7% -9.85% -8.58% 3.68% 4.94%
FCF Conversion (EBITDA) - - - - - - 26.95% 36%
FCF Conversion (Net income) - - - - - - 78.95% 96.92%
Dividend per Share 2 - - - - - - - -
Announcement Date 8/28/19 8/25/20 8/25/21 8/29/22 8/30/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2020 S1 2020 S2 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1
Net sales - - - - - - - -
EBITDA -1.874 -4.861 -2.516 1.182 2.924 2.06 6.263 -
EBIT -1.874 -6.897 -5.07 -3.43 -18.16 -2.305 -1.968 -
Operating Margin - - - - - - - -
Earnings before Tax (EBT) -3.946 - - -10.51 - -18.47 - -
Net income 1 -3.996 - - -10.52 - -18.18 - -10.71
Net margin - - - - - - - -
EPS 2 - - - - - - - -0.0177
Dividend per Share - - - - - - - -
Announcement Date 2/26/20 8/25/20 8/25/21 2/24/22 8/29/22 2/26/23 8/30/23 2/27/24
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 25.1 71.4 56.3 39 33.6 16.6 14.1 23.8
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 -6.75 -13.6 -17.2 -147 -12.1 -10.6 4.5 6.3
ROE (net income / shareholders' equity) -18.3% -22.1% -15% -3.84% -6.84% -0.64% 1.72% 3.55%
ROA (Net income/ Total Assets) -11.6% -10.2% -10.9% -9.43% -4.86% 1.8% 1.8% 2%
Assets 1 35.64 120 127.3 224.3 491.2 -550 316.7 325
Book Value Per Share 2 0.1300 0.2200 0.2500 0.4000 0.3700 0.3500 0.3400 0.3600
Cash Flow per Share - - -0.0300 -0 - - - -
Capex 1 0.2 0.33 6.23 17.2 - 0.1 0.7 0.7
Capex / Sales 0.99% 1.06% 14.2% 15.94% - 0.08% 0.57% 0.55%
Announcement Date 8/28/19 8/25/20 8/25/21 8/29/22 8/30/23 - - -
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.155 AUD
Average target price
0.39 AUD
Spread / Average Target
+151.61%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BTH Stock
  4. Financials Bigtincan Holdings Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW